|
Volumn 3, Issue 4, 2001, Pages 635-640
|
New therapies for the pregnant patient with diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
BIGUANIDE DERIVATIVE;
CHLORPROPAMIDE;
GLIBENCLAMIDE;
GLIPIZIDE;
GLUCOSE;
INSULIN;
INSULIN LISPRO;
METFORMIN;
PHENFORMIN;
SULFONYLUREA;
BIRTH INJURY;
CESAREAN SECTION;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
DISEASE EXACERBATION;
GLUCOSE BLOOD LEVEL;
HIGH RISK POPULATION;
HUMAN;
HYPERTENSION;
HYPOGLYCEMIA;
INSULIN PUMP;
INSULIN TREATMENT;
MACROSOMIA;
MATERNAL MORTALITY;
MATERNAL WELFARE;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PERINATAL MORTALITY;
PREECLAMPSIA;
PREGNANCY DIABETES MELLITUS;
PREMATURE LABOR;
PRIORITY JOURNAL;
REVIEW;
SPONTANEOUS ABORTION;
ABORTION, SPONTANEOUS;
CESAREAN SECTION;
DIABETES, GESTATIONAL;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
OBSTETRIC LABOR, PREMATURE;
PREGNANCY;
PREGNANCY IN DIABETICS;
|
EID: 0035724192
PISSN: 15209156
EISSN: None
Source Type: Journal
DOI: 10.1089/15209150152811270 Document Type: Review |
Times cited : (11)
|
References (26)
|